Skip to main content
VCbacked
Log inGet Started

Enterprise Therapeutics

Falmer, United Kingdom

A UK-based developer of drugs to treat respiratory diseases

$33.1M raised
Jan 2024
Series B
Health CareHealth DiagnosticsTherapeutics

Top Investors

Versant VenturesPanakes PartnersForbion Capital PartnersIP GroupNovartis Venture Fund

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Enterprise Therapeutics

How much funding has Enterprise Therapeutics raised?
Enterprise Therapeutics has raised $33.1M in total funding. The most recent round was Series B. The last funding was announced in January 2024.
Who are Enterprise Therapeutics's investors?
Enterprise Therapeutics's investors include Versant Ventures, Panakes Partners, Forbion Capital Partners, IP Group, Novartis Venture Fund.
Where is Enterprise Therapeutics headquartered?
Enterprise Therapeutics is headquartered in Falmer, United Kingdom.
What does Enterprise Therapeutics do?
A UK-based developer of drugs to treat respiratory diseases
What stage is Enterprise Therapeutics at?
Enterprise Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Enterprise Therapeutics — Funding & Investors." VCBacked, January 29, 2024, https://www.vcbacked.co/company/enterprise-therapeutics. Accessed June 17, 2026.
APA
VCBacked. (2024). Enterprise Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/enterprise-therapeutics
Wikipedia (cite web)
{{cite web |title=Enterprise Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/enterprise-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Virtuoso Surgical
Nashville
Basata
Phoenix
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Sedivention
Munich$848K